Skip to content

Article: NAD+ Deficiency Drives Kidney Dysfunction in Cockayne Syndrome: Preclinical Findings

NAD+ Deficiency Drives Kidney Dysfunction in Cockayne Syndrome: Preclinical Findings


Synopsis

Cockayne Syndrome (CS) is a premature aging disorder caused by mutations in the CSA and CSB genes, leading to problems like early aging, nerve damage, and kidney dysfunction. Cells from CS patients show low levels of NAD+, a molecule essential for cell health and kidney function. This study found that CS mice have severe kidney damage and impaired NAD+ production. In human kidney cells, reducing CSA or CSB caused persistent activation of a gene regulator (ATF3) that blocks a key enzyme for making NAD+, leading to low NAD+ levels and disrupted kidney cell function.

Journal

Cell Death & Differentiation

Read more

Cardiovascular Disease

Nicotinamide Riboside Improves Vascular and Cognitive Health in Peripheral Artery Disease: Clinical Findings

Objectives To investigate the potential for NR to counteract the age-related vascular and cognitive decline in peripheral artery disease (PAD) patients. Journal The Journal of Pharmacology and Exp...

Read more
Cancer

Nicotinamide Riboside and NMN Enhance CAR-T Cell Function in Aging: Preclinical Findings

Synopsis Chimeric antigen receptor (CAR) T cell therapy is a powerful cancer treatment, but its effectiveness declines with aging. This study found that CAR-T cells from aged female mice show mito...

Read more